---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-026903"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:08:30.241291+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sangamo shareholders approve increase in authorized shares and equity plan share reserve at annual meeting

## Summary
- Authorized common stock increased from 640M to 960M shares (320M increase).
- 2018 Equity Incentive Plan amended to add 11M shares to the reserve (total available now ~49.3M plus returning shares).
- All nine director nominees elected; advisory 'say-on-pay' passed with 101.3M votes for vs 15.1M against.
- Ratification of Ernst & Young as independent auditor for FY2024 approved with 151.1M votes for.

## SEC filing metadata
- accession: 0001628280-24-026903
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000162828024026903/0001628280-24-026903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000162828024026903/sgmo-20240604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-026903
- JSON: https://secwatch.observer/filing/0001628280-24-026903.json
- Plain text: https://secwatch.observer/filing/0001628280-24-026903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.